An SSMM-Informed Clinical Decision Architecture for Staged Laser Iris Depigmentation
Background: Laser iris depigmentation presents distinct questions of initial patient suitability, eye-specific safety, pigmentary response, and authorization of subsequent staged exposure. These decisions are often described together, although their information requirements and consequences are not interchangeable. Objective: To specify an auditable clinical decision architecture that integrates existing Lumineyes™ program eligibility policy, four-domain anterior-segment reassessment, longitudinal response documentation, and independent physician authorization while retaining explicit boundaries between clinical practice, conceptual frameworks, and unvalidated mechanisms. Methods: This technical note synthesizes the publicly available Lumineyes™ Laser Iris Depigmentation Clinical Practice Standard v1.0 (Zenodo DOI: 10.5281/zenodo.24256204), previously proposed Selective Stromal Melanin Modulation (SSMM) and Lumineyes Anterior-Segment Safety Staging (L-SAFE) frameworks, and selected ophthalmic clinical and methodological literature. Four decision gates, a minimum linked record, withholding and sequence-closure rules, and a staged external-validation plan were specified. No new patient-level dataset, clinician-reliability experiment, or treatment-outcome analysis was performed. Proposed output: The architecture separates (A) patient- and eye-level eligibility, (B) a complete eye-specific safety checkpoint, (C) documentation of prior-stage pigmentary and non-pigmentary response, and (D) an explicit stage-specific authorization decision. An S0 (READY) safety state does not itself authorize treatment. Incomplete mandatory observations cannot establish S0; S1 and S2 withhold additional exposure, whereas S3 terminates the current treatment sequence. A linked record preserves prior events, medication context, clinical rationale, and follow-up disposition. Conclusion: The contribution is a traceable decision and recording specification, not a validated safety or effectiveness algorithm. Feasibility, inter-rater reproducibility, independent outcome association, and external utility must be evaluated before any clinical benefit is inferred.
Authors
- Mete Mustafa (ORCID: https://orcid.org/0009-0004-3128-2853)
Publication Details
- Journal
- Preprints.org
- Published
- 2026-11-17
- DOI
- https://doi.org/10.20944/preprints202611.1650.v1
- Primary Topic
- Ocular and Laser Science Research
- Type
- preprint